Sen-SORE™ is the world’s first Smart Acupressure platform—a wearable biosensor device that translates forty years of clinical touch expertise into objective, measurable, and actionable pain data.

The Sen-SORE™ PAIN IQ Platform was developed to solve one of healthcare’s most persistent problems: the inability to objectively measure and document pain. By digitizing the proprietary PALM (Palpation, Acupressure, and Lymphatic Massage) clinical methodology, Sen-SORE™ captures real-time physiological biosignatures at the precise anatomical locations where soft tissue inflammation—the root cause of most musculoskeletal pain—manifests.

The result is a platform that simultaneously assesses the severity of pain objectively and treats it actively, without drugs, needles, or invasive procedures.

What is PAIN IQ?

PAIN IQ is the proprietary intelligence layer of the Sen-SORE™ platform. It is the software and data analytics framework that converts raw physiological sensor readings into a clinically meaningful, objective pain score. PAIN IQ enables:

Biosensor Technology: What We Measure

The Sen-SORE™ device integrates multiple sensor modalities to capture a comprehensive physiological profile of each pain point. These measurements are grounded in the clinical assessment principles of the PALM methodology, now digitized for precision and repeatability.

Biosensor Parameter	What It Detects	Clinical Significance
Skin Surface Temperature	Localized thermal elevation at soft tissue sites	Indicates active inflammation; a primary biomarker of injury and chronic pain
Galvanic Skin Response (GSR)	Electrodermal activity and sympathetic nervous system response	Reflects pain severity and stress response; correlates with pain intensity
Pain Pressure Threshold (PPT)	Minimum force required to elicit pain at a specific site	Quantifies sensitization and hyperalgesia; tracks treatment response over time
IPCM Compression Delivery	Controlled pneumatic pressure applied to target sites	Actively reduces edema and promotes lymphatic drainage at the pain source

Research & Development Foundation

The Sen-SORE™ platform was developed through a rigorous, grant-funded research and development process in collaboration with leading Canadian academic and research institutions:

• Centennial College WIMTACH Program — Wearable, Interactive, Mobile Technology Applied Research in Community Health. Co-developed the hardware and software architecture of the Sen-SORE™ device.
• Simon Fraser University (SFU) — Academic research collaboration validating the physiological measurement protocols and clinical assessment methodology.
• IRAP (Industrial Research Assistance Program) — National Research Council of Canada funding for applied R&D.
• Mitacs — Research internship and collaborative funding supporting clinical validation studies.
• ICBC (Insurance Corporation of British Columbia) — Research funding to validate the platform’s application in motor vehicle injury rehabilitation and pain documentation.

Market Opportunity

The global musculoskeletal pain management market represents a $635 billion annual opportunity. With an aging global population, rising rates of chronic pain, and increasing demand for non-pharmacological treatment options, the timing for an objective, wearable pain assessment and treatment platform has never been more critical.

“Pain must be recognized as a vital sign. With musculoskeletal pain affecting millions worldwide, there is an urgent need for objective, scalable, drug-free solutions that measure pain biosignatures and enable evidence-based treatment.”

— Sen-SORE™ Research Foundation